BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3955904)

  • 1. The natural history of IgA nephritis in Singapore.
    Woo KT; Edmondson RP; Wu AY; Chiang GS; Pwee HS; Lim CH
    Clin Nephrol; 1986 Jan; 25(1):15-21. PubMed ID: 3955904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors predicting progression of IgA nephropathies.
    Coppo R; D'Amico G
    J Nephrol; 2005; 18(5):503-12. PubMed ID: 16299675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature.
    Ibels LS; Györy AZ
    Medicine (Baltimore); 1994 Mar; 73(2):79-102. PubMed ID: 8152367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
    Packham DK; Yan HD; Hewitson TD; Nicholls KM; Fairley KF; Kincaid-Smith P; Becker GJ
    Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T; Fernando ME; Jayakumar M
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerulonephritis in Singapore: an overview.
    Woo KT; Chiang GS; Edmondson RP; Wu AY; Lee EJ; Pwee HS; Lim CH
    Ann Acad Med Singap; 1986 Jan; 15(1):20-31. PubMed ID: 3707031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and natural history of IgA nephropathy.
    Rychlik I; Andrassy K; Waldherr R; Zuna I; Tesar V; Jancová E; Stejskalová A; Ritz E
    Ann Med Interne (Paris); 1999 Feb; 150(2):117-26. PubMed ID: 10392260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "point of no return" and the rate of progression in the natural history of IgA nephritis.
    Schöll U; Wastl U; Risler T; Braun N; Grabensee B; Heering P; Schollmeyer P; Zäuner I; Stein G; Fünfstück R; Keller F
    Clin Nephrol; 1999 Nov; 52(5):285-92. PubMed ID: 10584991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K; Yu Y; Tang Z; Liu Z; Li L
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgA nephropathy in patients over 50 years of age: a multicentre, prospective study.
    Frimat L; Hestin D; Aymard B; Mayeux D; Renoult E; Kessler M
    Nephrol Dial Transplant; 1996 Jun; 11(6):1043-7. PubMed ID: 8671966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study.
    Manno C; Strippoli GF; D'Altri C; Torres D; Rossini M; Schena FP
    Am J Kidney Dis; 2007 Jun; 49(6):763-75. PubMed ID: 17533019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee's glomerular grading system.
    Lee HS; Lee MS; Lee SM; Lee SY; Lee ES; Lee EY; Park SY; Han JS; Kim S; Lee JS
    Nephrol Dial Transplant; 2005 Feb; 20(2):342-8. PubMed ID: 15618239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of primary IgA nephropathy.
    Berthoux FC; Mohey H; Afiani A
    Semin Nephrol; 2008 Jan; 28(1):4-9. PubMed ID: 18222341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation, prognosis and outcome of IgA nephropathy in Indian adults.
    Chacko B; John GT; Neelakantan N; Korula A; Balakrishnan N; Kirubakaran MG; Jacob CK
    Nephrology (Carlton); 2005 Oct; 10(5):496-503. PubMed ID: 16221102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
    Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
    Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.